GLP-1 agonist polypeptide compound and salt thereof, synthesis method therefor and use thereof
Grant
US12590134B2
Kind: B2
Mar 31, 2026
Assignee
SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD.
Inventors
Chengqing Zhao, Guoqiang Shi, Shunzi Li, Caidian Wang
Abstract
The disclosure provides a GLP-1 agonist polypeptide compound having an amino acid sequence: H Xaa1EGTFTSDVSSYLE Xaa2QAA Xaa3EFIAWLVRGRG (SEQ ID NO: 1). The C-terminal amino acid of the polypeptide compound is a carboxyl or the carboxyl is amidated. Xaa1 and Xaa2 are the same or different; R1 is: a straight-chain or branched-chain alkyl containing 2-6 carbon atoms, R2 is: H or CH3, X is: O, S or N—CH3, in the formula, R1 and R2 alkyl is optionally substituted by 1-6 halogen atoms.
CPC Classifications
C07K 14/605
C07K 14/001
A61K 38/00
A61P 3/04
A61P 3/10
Filing Date
2022-08-17
Application No.
17820251
Claims
2